|
HCFC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.026810E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.176180E-02 |
| Normal-vs-Stage2 |
6.721000E-01 |
| Normal-vs-Stage3 |
8.834800E-01 |
| Normal-vs-Stage4 |
1.013690E-02 |
| Stage1-vs-Stage2 |
2.881200E-01 |
| Stage1-vs-Stage3 |
1.059440E-01 |
| Stage1-vs-Stage4 |
3.060800E-01 |
| Stage2-vs-Stage3 |
8.012800E-01 |
| Stage2-vs-Stage4 |
1.755440E-01 |
| Stage3-vs-Stage4 |
1.031000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.474100E-02 |
| Normal-vs-AfricanAmerican |
5.067900E-02 |
| Normal-vs-Asian |
1.005550E-02 |
| Caucasian-vs-AfricanAmerican |
4.152000E-01 |
| Caucasian-vs-Asian |
2.023200E-01 |
| AfricanAmerican-vs-Asian |
2.480200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.376440E-02 |
| Normal-vs-Female |
5.217400E-01 |
| Male-vs-Female |
4.641600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.753600E-02 |
| Normal-vs-Extreme_Weight |
4.661400E-03 |
| Normal-vs-Obese |
6.395400E-01 |
| Normal-vs-Extreme_Obese |
6.071900E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.362600E-01 |
| Normal_Weight-vs-Obese |
2.123800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.109000E-01 |
| Extreme_Weight-vs-Obese |
2.326300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.509400E-01 |
| Obese-vs-Extreme_Obese |
2.350800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.400600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.146800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.999510E-02 |
| Normal-vs-Age(81-100Yrs) |
2.238200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.718600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.158770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.797400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.457500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.232400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.862220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.810010E-01 |
| Normal-VS-Type2 PRCC |
6.903500E-03 |
| Normal-VS-KIRP CIMP |
6.985800E-01 |
| Normal-VS-Unclassified PRCC |
5.449600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.199600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.995800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.397800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.964400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.584600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.375200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.755400E-03 |
| Normal-vs-N1 |
6.237200E-01 |
| Normal-vs-N2 |
9.805800E-01 |
| N0-vs-N1 |
1.552620E-01 |
| N0-vs-N2 |
3.361000E-01 |
| N1-vs-N2 |
8.427200E-01 |
|
|
